Using Empirical Data to Inform the Ethical Evaluation of Placebo Controlled Trials

Science and Engineering Ethics

Volumn 10, Issue 1, 2004, Pages 29-35

  Sugarman, Jeremy ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Clinical trials; Ethics; Placebos; Research ethics

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; DIETHYLCARBAMAZINE; PLACEBO; ZIDOVUDINE;

CLINICAL RESEARCH; CLINICAL TRIAL; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; DECISION MAKING; DEPRESSION; DRUG FATALITY; EMPIRICAL RESEARCH; EYE DISEASE; HEART INFARCTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; KIDNEY DISEASE; LITERATURE; MEDICAL ETHICS; MENTAL DISEASE; META ANALYSIS; ONCHOCERCIASIS; RHEUMATOID ARTHRITIS; SCHIZOPHRENIA; STROKE; SUICIDE; SUICIDE ATTEMPT; VERTICAL TRANSMISSION; VIRUS TRANSMISSION;

EID: 1242306790     PISSN: 13533452     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11948-004-0059-8     Document Type: Conference Paper

References (21)

1. Temple, R., Ellenberg, S.S. (2000) Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 1: ethical and scientific issues, Annals of Internal Medicine 133: 455-63.
2. Temple, R., Ellenberg, S.S. (2000) Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 2: practical issues and specific cases, Annals of Internal Medicine 133: 464-470.
3. Sugarman, J. (2002) Ethics in the design and conduct of clinical research, Epidemiologic Reviews 24: 54-58.
4. Lavori, P.W., Sugarman, J., Hays, M.T., Feussner, J.R. (1999) Improving informed consent in clinical trials: a duty to experiment, Controlled Clinical Trials 20: 187-193.
5. Rothman, K.J., Michels, K.B. (1994) The continuing unethical use of placebo controls, New England Journal of Medicine 331: 394-398.
6. Greene, B.M., Taylor, H.R., Cupp, E.W., et al. (1985) Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis, New England Journal of Medicine 313: 133-138.
7. Taylor, H.R. (1995) The use of placebo controls, New England Journal of Medicine 33: 60-61.
8. Angell, M. (1997) The ethics of clinical research in the third world, New England Journal of Medicine 337: 847-849.
9. Macklin, R. (1998). Justice in international research, in: Kahn, J.P., Mastroianni A.M., & Sugarman, J., eds. Beyond consent: seeking justice in research, Oxford University Press, pp. 131-146.
10. World Medical Association, (2000), Declaration of Helsinki, http://www.wma.net/e/policy/17-c_e.html.
11. Freedman, B., Weijer, C., Glass, K.C. (1996) Placebo orthodoxy in clinical research I: empirical and methodological myths, Journal of Law, Medicine and Ethics 24: 243-251.
12. Freedman, B., Glass, K.C., Weijer, C. (1996) Placebo orthodoxy in clinical research II: ethical, legal, and regulatory myths, Journal of Law, Medicine and Ethics 24: 252-9.
13. Emanuel, E.J., Miller, F.G. (2001) The ethics of placebo-controlled trials - a middle ground, New England Journal of Medicine 345: 915-919.
14. International Conference for Harmonization of Technical Requirements for the Registration of Pharmaceuticals for Human Use (ICH), "Topic E10: Choice of control group in clinical trials," The European Agency for the Evaluation of Medicinal Products, London, July 2000. See www.ifpma.org/ich7. html.
15. Al-Khatib, S.M., Califf, R.M., Hasselblad, V., Alexander, J.H., McCrory, D.C., Sugarman, J. (2001) Placebo-controls in short-term clinical trials of hypertension, Science 292: 2013-2015.
16. Halperin S.D., Ubel, P.A., Berlin, J.A., Townsend, R.R., Asch, D.A. (2002) Physicians' preferences for active-controlled versus placebo-controlled trials of new antihypertensive drugs, Journal of General Internal Medicine 17: 689-695.
17. Boisaubin, E.V. (2002) Practitioners and clinical trials: true to your patients - or science? Journal of General Internal Medicine 17: 738-739.
18. Charney, D.S., Nemeoff, C.B., Lewis, L., et al. (2002) National Depressive and Manic-Depressive Association consensus statement on the use of placebo in clinical trials of mood disorders, Archives of General Psychiatry 59: 262-270.
19. Khan, A., Warner, H.A., Brown, W.A. (2000) Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials, Archives of General Psychiatry 57: 311-317.
20. Storosum J.G., van Zwieten, B.J., Wohlfarth T., de Haan, L., Khan, A., van den Brink, W. (2003) Suicide risk in placebo-controlled trials for schizophrenia, Archives of General Psychiatry 60: 365-368.
21. Lavori, P. W., Sugarman, J. (2000) Placebo revisited, Acta Psychiatrica Scandinavica 101: 173-175.